To further substantiate our hypothesis, we next performed a meta-analysis on the published literature including studies that correlated the ABCB1/ABCG2 genotype and imatinib plasma Ctrough in GIST and CML. This evidence concerns the gene ABCB1 and chronic myelogenous leukemia, BCR-ABL1 positive.